Embecta Corp. financial data

Symbol
EMBC on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1209 Orange Street, Wilmington, DE
State of incorporation
DE
Fiscal year end
September 30
Former names
Berra Newco, Inc. (to 9/3/2021)
Latest financial report
10-K - Q3 2024 - Dec 11, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 215 % +3.31%
Quick Ratio 47.7 % +12.3%
Return On Equity -10.2 % -19.4%
Return On Assets 6.3 % +9%
Operating Margin 14.9 % -24.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.1M shares +0.96%
Common Stock, Shares, Outstanding 57.7M shares +0.65%
Entity Public Float 763M USD -52.3%
Common Stock, Value, Issued 600K USD 0%
Weighted Average Number of Shares Outstanding, Basic 57.7M shares +0.76%
Weighted Average Number of Shares Outstanding, Diluted 58.3M shares +0.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.12B USD +0.21%
Research and Development Expense 78.8M USD -7.51%
Operating Income (Loss) 167M USD -24.7%
Nonoperating Income (Expense) -10.3M USD -17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 44.2M USD -58.2%
Income Tax Expense (Benefit) -34.1M USD -197%
Net Income (Loss) Attributable to Parent 78.3M USD +11.2%
Earnings Per Share, Basic 1.36 USD/shares +10.6%
Earnings Per Share, Diluted 1.34 USD/shares +9.84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 268M USD -18%
Accounts Receivable, after Allowance for Credit Loss, Current 193M USD +1056%
Inventory, Net 172M USD +12.8%
Other Assets, Current 68.5M USD -38.5%
Assets, Current 761M USD +1.59%
Property, Plant and Equipment, Net 356M USD
Operating Lease, Right-of-Use Asset 22.6M USD -1.74%
Goodwill 15.6M USD 0%
Other Assets, Noncurrent 68.5M USD
Assets 1.29B USD +5.84%
Accounts Payable, Current 64.3M USD
Employee-related Liabilities, Current 66.7M USD +7.41%
Accrued Liabilities, Current 134M USD +13.6%
Liabilities, Current 374M USD +5.8%
Operating Lease, Liability, Noncurrent 11.9M USD -22.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -293M USD +5.27%
Retained Earnings (Accumulated Deficit) -499M USD +7.85%
Stockholders' Equity Attributable to Parent -738M USD +10.2%
Liabilities and Equity 1.29B USD +5.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -122%
Net Cash Provided by (Used in) Financing Activities -13.5M USD -121%
Net Cash Provided by (Used in) Investing Activities -2.7M USD +42.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 57.7M shares +0.65%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -27.8M USD -151%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 274M USD -16%
Deferred Tax Assets, Valuation Allowance 50.2M USD +58.9%
Deferred Tax Assets, Gross 191M USD +74.2%
Operating Lease, Liability 17.9M USD -16%
Payments to Acquire Property, Plant, and Equipment 2.7M USD -42.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 94.6M USD +9.75%
Lessee, Operating Lease, Liability, to be Paid 22.2M USD -19.3%
Property, Plant and Equipment, Gross 775M USD
Operating Lease, Liability, Current 6M USD +1.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.4M USD -5.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.2M USD +10.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) -17M USD -1314%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.3M USD -30.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.8M USD -35.7%
Unrecognized Tax Benefits 13.5M USD +43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.8M USD -18.2%
Operating Lease, Payments 1.4M USD
Additional Paid in Capital 52.5M USD +88.2%
Amortization of Intangible Assets 300K USD -40%
Depreciation, Depletion and Amortization 8.8M USD +22.2%
Deferred Tax Assets, Net of Valuation Allowance 141M USD +80.4%
Share-based Payment Arrangement, Expense 26.6M USD +21.5%
Interest Expense 4.9M USD